CHI3L1 and Alzheimer disease: In the longitudinal early-onset AD study (LEADS), the results showed that cerebrospinal fluid (CSF) biomarkers were correlated with each other including CHI3L1, and CSF CHI3L1 was associated with cognition and astrocytic changes during the early onset of AD [41,83].